Sea Buckthorn's Effects on Liver Fibrosis

Sea buckthorn (Hippophae rhamnoides L.), often called a "superfruit," is a hardy shrub native to cold regions of Europe and Asia, with bright orange berries packed with vitamins (especially C and E), flavonoids, carotenoids, polyphenols, fatty acids, and other bioactive compounds. Traditionally used in folk medicine for various ailments, modern research highlights its potential hepatoprotective effects, including against liver fibrosis — the progressive scarring of liver tissue resulting from chronic inflammation, injury, or diseases like hepatitis, alcohol abuse, or metabolic disorders.

Liver fibrosis occurs when repeated liver damage activates hepatic stellate cells (HSCs), the main drivers of fibrosis. In a healthy liver, HSCs store vitamin A and remain quiescent. Chronic injury causes them to activate into myofibroblast-like cells, proliferating and overproducing extracellular matrix (ECM) components like collagens (types III and IV), laminin, and hyaluronic acid. This leads to scarring, impaired liver function, and potentially irreversible cirrhosis if unchecked. Preventing or reversing fibrosis often targets HSC activation, inflammation, oxidative stress, and ECM deposition.

Sea buckthorn shows promise in mitigating these processes through its rich antioxidant and anti-inflammatory profile.

Evidence from Studies

A key clinical study involved 50 patients with liver cirrhosis (Child-Pugh grades A and B), randomly divided into a treatment group receiving oral sea buckthorn extract (15 g three times daily for 6 months) and a control group. The treatment significantly reduced serum markers of fibrosis, including laminin (LN), hyaluronic acid (HA), collagen types III and IV, and total bile acids (TBA). It also shortened the time for aminotransferase normalization, indicating improved liver function. The authors concluded that sea buckthorn may restrain collagen and ECM synthesis, positioning it as a hopeful agent for preventing and treating liver fibrosis, though larger controlled trials are needed. (1)

In preclinical research, active components isolated from sea buckthorn berries (e.g., compounds labeled C13, C15, and C32) strongly inhibited TGF-β-induced HSC activation in vitro, reducing inflammatory factors and α-smooth muscle actin (α-SMA, a marker of activated HSCs). These compounds upregulated the DNA damage signaling pathway, potentially impairing HSC DNA repair, inducing apoptosis in damaged cells, and suppressing TGF-β effects. In rats with bile duct ligation (BDL)-induced fibrosis, sea buckthorn treatment attenuated fibrosis progression dose-dependently, lowering liver injury/inflammation markers and restoring function while downregulating α-SMA.

Liu et al. found supporting evidence related to active components regulating HSCs and fibrogenesis, as referenced in multiple sources including PubMed abstract from 2018).

Other animal models support hepatoprotection, such as reduced oxidative stress, inflammation, and lipid accumulation in high-fat or toxin-induced liver injury, aligning with antifibrotic potential.

Mechanisms of Action

Sea buckthorn's benefits stem from multiple synergistic mechanisms:

1. Antioxidant activity — Rich in polyphenols, flavonoids (e.g., isorhamnetin, quercetin derivatives), vitamin C/E, and carotenoids, it neutralizes reactive oxygen species (ROS), reducing oxidative stress that activates HSCs and promotes inflammation/fibrosis.

2. Anti-inflammatory effects — Lowers pro-inflammatory cytokines like TNF-α and IL-6 (elevated in fibrosis), modulating pathways like NF-κB to curb chronic inflammation driving HSC activation.

3. Inhibition of HSC activation and ECM production — Suppresses TGF-β signaling (central to fibrosis), reduces α-SMA expression, and limits collagen/laminin/HA synthesis. Some components may induce HSC apoptosis by disrupting DNA repair in activated cells.

4. Restoration of quiescent HSC state — Potential to support vitamin A/retinoic acid receptor (RAR) retention in HSCs, preventing transdifferentiation into myofibroblasts.

These actions collectively prevent progression and may aid reversal in early fibrosis stages by reducing ECM buildup and promoting resolution.

Sources

Gao ZL, Gu XH, Cheng FT, Jiang FH. Effect of Sea buckthorn on liver fibrosis: A clinical study. World J Gastroenterol. 2003;9(7):1615-1617.